When.com Web Search

  1. Ads

    related to: dipeptidyl peptidase 4 inhibitor drugs uses and benefits weight loss dosage

Search results

  1. Results From The WOW.Com Content Network
  2. Dipeptidyl peptidase-4 inhibitor - Wikipedia

    en.wikipedia.org/wiki/Dipeptidyl_peptidase-4...

    DPP-4 inhibitors and GLP-1. Inhibitors of dipeptidyl peptidase 4 (DPP-4 inhibitors or gliptins) are a class of oral hypoglycemics that block the enzyme dipeptidyl peptidase-4 (DPP-4). They can be used to treat diabetes mellitus type 2. The first agent of the class – sitagliptin – was approved by the FDA in 2006. [1]

  3. Discovery and development of dipeptidyl peptidase-4 inhibitors

    en.wikipedia.org/wiki/Discovery_and_development...

    One of the first reported DPP-4 inhibitor was P32/98 from Merck. It used thiazolidide as the P1-substitute and was the first DPP-4 inhibitor that showed effects in both animals and humans but it was not developed to a market drug due to side effects. Another old inhibitor is DPP-728 from Novartis, where 2-cyanopyrrolidine is used as the P1 ...

  4. Diabetes medication - Wikipedia

    en.wikipedia.org/wiki/Diabetes_medication

    GLP-1 analogs resulted in weight loss and had more gastrointestinal side-effects, while in general dipeptidyl peptidase-4 (DPP-4) inhibitors were weight-neutral and are associated with increased risk for infection and headache. Both classes appear to present an alternative to other antidiabetic drugs.

  5. Are Diabetes Drugs Really Safe (& Reliable) for Weight Loss?

    www.aol.com/diabetes-drugs-really-safe-reliable...

    This leads the pancreas to produce more insulin, which helps lower blood sugar levels and promote weight loss. GLP-1 drugs for weight loss and type 2 diabetes include dulaglutide, liraglutide, and ...

  6. Dipeptidyl peptidase-4 - Wikipedia

    en.wikipedia.org/wiki/Dipeptidyl_peptidase-4

    A class of oral hypoglycemics called dipeptidyl peptidase-4 inhibitors works by inhibiting the action of this enzyme, thereby prolonging incretin effect in vivo. [18] Middle East respiratory syndrome coronavirus has been found to bind to DPP4. It is found on the surface of cells in the airways (such as the lungs) and kidneys.

  7. Saxagliptin - Wikipedia

    en.wikipedia.org/wiki/Saxagliptin

    Saxagliptin, sold under the brand name Onglyza, is an oral hypoglycemic (anti-diabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class. [1] [2] Early development was solely by Bristol-Myers Squibb; in 2007 AstraZeneca joined with Bristol-Myers Squibb to co-develop the final compound and collaborate on the marketing of the drug.

  1. Ad

    related to: dipeptidyl peptidase 4 inhibitor drugs uses and benefits weight loss dosage